Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.

Taipei - Lotus Pharmaceuticals , a multinational pharmaceutical company, reported Q2 2023 audited financial results.
Q2 2023 financial highlights
Lotus delivered another successful quarter in Q2 '23....
-Today at 09:42 am- MarketScreener

Related Keywords

Japan , Brazil , New Zealand , Taiwan , Thailand , Canada , Taipei , T Ai Pei , Lotu , Qinghai , China , Susan Liao , Petar Vazharov , Lotus , Business Development , Lotus Pharmaceuticals , Out Deals , Chief Executive Officer , News Publishing , Markets ,